Article
Brochure
Executive Resource
Insight Hub
Ext. Publication
Video
Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- Executive & Leadership Coaching
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Sustainability Consulting
- Transaction Advisory
- Trust & Estate
- Valuation
PodcastRetail real estate leaders discuss consumer demand, ecommerce, experiential retail and the factors shaping commercial retail development.
The SBIR and STTR reauthorization brings larger awards, stricter eligibility and more competition for life sciences companies seeking federal funding.
Learn why Texas is a leading life sciences hub, from workforce to funding. Discover what’s driving growth and what it means for companies.
Tariff refunds, economic damages and importers: Supreme Court and trade rulings raise claims and recovery questions for businesses.
A Supreme Court ruling has opened the door to tariff refunds. Here’s what recent updates mean for importers and potential claims.
Texas life sciences in 2025 saw concentrated capital, declining innovation output and earlier‑stage clinical shifts shaping the ecosystem.
Texas life sciences saw record capital in Q4 2025, even as innovation, early-stage funding and late-phase clinical trials continued to decline.
Success StoryWeaver created a durable environmental reporting framework for a global supplier: greenhouse gas tracking, audit readiness and sustainability.
Explore Q3 2025 trends in Texas life sciences, from Series B collapse and pipeline bottlenecks to sector divergence and record late-stage capital.
Explore Q2 2025 trends in Texas life sciences, from capital selectivity and pipeline constraints to market recovery and beyond.
Explore Q1 2025 trends in Texas life sciences, from capital concentration and clinical momentum to innovation and public market dynamics.
Life sciences companies often overlook SOX in IPO prep. Discover how early action and targeted strategies can strengthen investor confidence.
